concept

LYMPHOMA

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about LYMPHOMA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

823Connections

0Hypotheses

0Analyses

50Outgoing

50Incoming

0Experiments

0Debates

Summary

LYMPHOMA is a concept in neurodegeneration research. Key relationships include: co discussed, interacts with, causes. Associated with LEUKEMIA, TUMOR. Connected to 27 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	LYMPHOMA
Key Genes/Proteins	AKT, AMPK, BAX, BCL2, BCR, BDNF
Related Diseases	BREAST CANCER, CANCER, CELL DEATH

Pathway Diagram

graph TD
    LYMPHOMA["LYMPHOMA"]
    LYMPHOMA -->|"activates"| Ferroptosis["Ferroptosis"]
    LYMPHOMA -->|"inhibits"| Apoptosis["Apoptosis"]
    LYMPHOMA -->|"activates"| Immune_Response["Immune Response"]
    LYMPHOMA -->|"activates"| Epigenetic["Epigenetic"]
    LYMPHOMA -->|"contributes to"| Sphingolipid["Sphingolipid"]
    LYMPHOMA -->|"target for"| Pi3K["Pi3K"]
    TFR1["TFR1"] -.biomarker for.-> LYMPHOMA
    JUN["JUN"] -->|"inhibits"| LYMPHOMA
    ACSL4["ACSL4"] -->|"regulates"| LYMPHOMA
    GPX4["GPX4"] -->|"regulates"| LYMPHOMA
    DICER1["DICER1"] -->|"regulates"| LYMPHOMA
    RPA1["RPA1"] -->|"inhibits"| LYMPHOMA
    STAT3["STAT3"] -->|"activates"| LYMPHOMA
    AGO2["AGO2"] -->|"inhibits"| LYMPHOMA

Outgoing (198)

Target	Relation	Type	Str
Apoptosis	activates	pathway	1.00
Apoptosis	regulates	pathway	1.00
Apoptosis	therapeutic_target	pathway	1.00
Apoptosis	inhibits	pathway	1.00
Inflammation	activates	disease	0.85
Pi3K/Akt	therapeutic_target	pathway	0.80
Autophagy	associated_with	pathway	0.80
Mtor	therapeutic_target	pathway	0.80
Lung Cancer	associated_with	disease	0.75
Drug Resistance	therapeutic_target	pathway	0.70
Ferroptosis	activates	pathway	0.70
Autophagy	inhibits	pathway	0.70
Nf-Κb	activates	pathway	0.70
Immune Response	activates	pathway	0.70
Angiogenesis	therapeutic_target	pathway	0.70
Autophagy	activates	pathway	0.70
Mapk	therapeutic_target	pathway	0.70
Mtor	activates	pathway	0.70
Apoptosis	associated_with	pathway	0.70
P53	inhibits	gene	0.65
PI3K	activates	gene	0.65
P53	interacts_with	gene	0.65
Autoimmune	activates	disease	0.65
Lung Cancer	therapeutic_target	disease	0.65
FERROPTOSIS	treats	phenotype	0.65
Ferroptosis	regulates	pathway	0.60
Immunotherapy	treats	pathway	0.60
MACROPHAGES	regulates	cell_type	0.60
T CELL	causes	cell_type	0.60
Erk Signaling	activates	pathway	0.60
Car-T	associated_with	pathway	0.60
Immunotherapy	regulates	pathway	0.60
Ras/Raf/Mek	therapeutic_target	pathway	0.60
MACROPHAGE	regulates	cell_type	0.60
Epigenetic	inhibits	pathway	0.60
Cell Cycle	therapeutic_target	pathway	0.60
Nf-Κb	expressed_in	pathway	0.60
Senescence	expressed_in	pathway	0.60
Autophagy	regulates	pathway	0.60
Stem Cell	inhibits	pathway	0.60
Checkpoint Inhibitor	therapeutic_target	pathway	0.60
Dna Repair	inhibits	pathway	0.60
Microrna	activates	pathway	0.60
Differentiation	therapeutic_target	pathway	0.60
Immunotherapy	therapeutic_target	pathway	0.60
Differentiation	activates	pathway	0.60
Oxidative Stress	activates	pathway	0.60
Proteasome	therapeutic_target	pathway	0.60
Toll-Like Receptor	activates	pathway	0.60
Angiogenesis	activates	pathway	0.60

Incoming (625)

Source	Relation	Type	Str
Als	activates	disease	1.00
BCL2	activates	gene	1.00
CANCER	inhibits	gene	1.00
Cancer	regulates	disease	1.00
BCL-2	therapeutic_target	gene	1.00
APOPTOSIS	therapeutic_target	gene	1.00
CANCER	therapeutic_target	gene	1.00
CANCER	regulates	gene	1.00
Cancer	associated_with	disease	1.00
Tumor	therapeutic_target	disease	1.00
APOPTOSIS	activates	gene	1.00
CANCER	associated_with	gene	1.00
Cancer	therapeutic_target	disease	1.00
APOPTOSIS	inhibits	gene	1.00
Als	therapeutic_target	disease	1.00
BAX	regulates	gene	1.00
AKT	therapeutic_target	gene	1.00
APOPTOSIS	regulates	gene	1.00
BCL-2	regulates	gene	1.00
MYC	associated_with	gene	0.95
STAT3	activates	gene	0.95
BCL2	associated_with	gene	0.95
INFLAMMATION	activates	gene	0.95
PI3K	therapeutic_target	gene	0.95
GENES	therapeutic_target	gene	0.95
EGFR	inhibits	gene	0.95
Cancer	inhibits	disease	0.95
Als	associated_with	disease	0.95
Tumor	inhibits	disease	0.85
Tumor	associated_with	disease	0.85
EGFR MUTATIONS	inhibits	gene	0.85
HO-1	activates	gene	0.85
Carcinoma	inhibits	disease	0.85
DNA	regulates	gene	0.85
NRF2	activates	gene	0.85
AKT	activates	gene	0.85
MYC	activates	gene	0.85
BCL2	inhibits	gene	0.85
P53	inhibits	gene	0.85
MTOR	activates	gene	0.85
MTOR	therapeutic_target	gene	0.85
NUCLEAR JAK	contributes_to	protein	0.85
B CELLS	activates	cell_type	0.80
ERK1	activates	gene	0.75
Leukemia	inhibits	disease	0.75
BCL2	expressed_in	gene	0.75
OXIDATIVE STRESS	activates	gene	0.75
NF-ΚB	expressed_in	gene	0.75
CYTOKINES	activates	gene	0.75
BAX	therapeutic_target	gene	0.75

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning LYMPHOMA in their description or question text

No additional research found